Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Embryonic Stem Cells

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.

Embryonic Stem Cells

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Source And Potency Of Stem Cells

Source And Potency Of Stem Cells

Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Synergistic Interactions Between the Quinolone-Derived Compound HT61 and Tobramycin Against a Range of Clinical Isolates of Pseudomonas aeruginosa In Vitro.

Lung·2025

Same author

A novel murine model of pulmonary fibrosis: the role of platelets in chronic changes induced by bleomycin.

Journal of pharmacological and toxicological methods·2021

Same author

The small quinolone derived compound HT61 enhances the effect of tobramycin against Pseudomonas aeruginosa in vitro and in vivo.

Pulmonary pharmacology & therapeutics·2019

Same author

Pharmacology and Therapeutics of Bronchodilators Revisited.

Pharmacological reviews·2019

Same author

Radiolabelling and immunohistochemistry reveal platelet recruitment into lungs and platelet migration into airspaces following LPS inhalation in mice.

Journal of pharmacological and toxicological methods·2019

Same author

Use of animal models in IPF research.

Pulmonary pharmacology & therapeutics·2018

Search research articles

Related Experiment Video

Updated: Jul 2, 2026

Generation of ESC-derived Mouse Airway Epithelial Cells Using Decellularized Lung Scaffolds

Generation of ESC-derived Mouse Airway Epithelial Cells Using Decellularized Lung Scaffolds

Published on: May 5, 2016

Human embryonic stem cells and lung regeneration.

A Varanou¹, C P Page, S L Minger

¹King's College London, Stem Cell Biology Laboratory, Wolfson Centre for Age-Related Diseases, London, UK. katerina.varanou@kcl.ac.uk

British Journal of Pharmacology

|August 30, 2008

Summary

Human embryonic stem cells offer a promising source for regenerative medicine, particularly for lung diseases. Researchers are developing methods to generate specific lung cells for transplantation and gene therapy.

More Related Videos

Generation of 3D Whole Lung Organoids from Induced Pluripotent Stem Cells for Modeling Lung Developmental Biology and Disease

Generation of 3D Whole Lung Organoids from Induced Pluripotent Stem Cells for Modeling Lung Developmental Biology and Disease

Published on: April 12, 2021

Related Experiment Videos

Last Updated: Jul 2, 2026

Generation of ESC-derived Mouse Airway Epithelial Cells Using Decellularized Lung Scaffolds

Generation of ESC-derived Mouse Airway Epithelial Cells Using Decellularized Lung Scaffolds

Published on: May 5, 2016

Generation of 3D Whole Lung Organoids from Induced Pluripotent Stem Cells for Modeling Lung Developmental Biology and Disease

Generation of 3D Whole Lung Organoids from Induced Pluripotent Stem Cells for Modeling Lung Developmental Biology and Disease

Published on: April 12, 2021

Area of Science:

Regenerative Medicine
Developmental Biology
Pharmacology

Background:

Human embryonic stem cells (hESCs) are pluripotent cells with the potential to differentiate into all cell types.
hESCs are of significant interest for regenerative medicine, targeting diseases lacking effective treatments.
Current research focuses on hESC applications in neurodegenerative, cardiac, retinal, lung, and liver diseases.

Purpose of the Study:

To explore the potential of human embryonic stem cells in regenerative medicine.
To develop methods for cell therapy and gene therapy using hESCs.
To investigate the generation of specific cell types, such as type II pneumocytes, from hESCs for pulmonary research.

Main Methods:

Derivation of pluripotent cells from the inner cell mass of preimplantation embryos.
In vitro culture and differentiation of hESCs.
Generation of enriched cultures of type II pneumocytes.

Main Results:

Successful generation of enriched type II pneumocyte cultures in vitro from hESCs.
Demonstrated potential for indefinite proliferation of hESCs in vitro.
Established hESCs as a potential source for unlimited cell supply for transplantation and gene therapy.

Conclusions:

hESC-derived cells hold significant promise for treating various pathological conditions.
The ability to generate specific cell types like type II pneumocytes advances understanding of biological processes.
This research could dramatically alter disease understanding and management, especially in pulmonary medicine.